论文部分内容阅读
目的 :探讨高原地区羟基磷灰石义眼台植入术的效果及安全性。方法 :对 8例 (8眼 )眼球萎缩或眼球缺如患者施行Ⅰ期或Ⅱ期羟基磷灰石义眼台植入术 ,观察手术效果及术后并发症。结果 :8例患者术后均达到满意效果 ,眼窝成形好 ,安装义眼后外观满意。Ⅰ期植入术患者眼球向各方向转动均良好 ,Ⅱ期植入术患者眼球向外转略差。术后均无感染、结膜裂开及义眼台排斥。 5例 (6 2 .5 % )球结膜水肿持续 4周以上 ,1例 (12 .5 % )术后眶压高 ,经治疗症状消失。结论 :高原地区羟基磷灰石义眼台植入术安全有效 ,术后并发症少
Objective: To investigate the efficacy and safety of hydroxyapatite orbital implantation in the plateau. Methods: Eight cases (eight eyes) of atrophy or lack of eye patients underwent stage Ⅰ or Ⅱ hydroxyapatite artificial eye implantation, the observation of surgical results and postoperative complications. Results: All the 8 patients achieved satisfactory results after operation. The eye socket was well formed and the appearance was satisfactory after the eye was installed. Patients with stage Ⅰ implantation turned well in all directions, while patients with stage Ⅱ implantation had slightly worse outward eyeballs. No infection after surgery, conjunctival rupture and prosthetic eye rejection. In 5 cases (62.5%), the conjunctival edema persisted for more than 4 weeks. One case (12.5%) had high orbital pressure and disappeared after treatment. Conclusion: Hydroxyapatite artificial eye implantation in the plateau is safe and effective, with fewer postoperative complications